Lecture 22 - Ganglionic and Neuromuscular Blockers

0.0(0)
studied byStudied by 0 people
0.0(0)
linked notesView linked note
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/165

flashcard set

Earn XP

Description and Tags

A comprehensive set of flashcards designed to review key concepts, historical discoveries, and pharmaceutical advancements in the field of ganglionic and neuromuscular blockers.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

166 Terms

1
New cards

What is the primary concept introduced in the lecture on ganglionic and neuromuscular blockers?

The concept of ganglionic and neuromuscular blocking agents.

2
New cards

What is tubocurarine known for?

It was the first nicotinic antagonist discovered.

3
New cards

What are the two types of neuromuscular junction blockers?

Nondepolarizing agents (competitive antagonists) and depolarizing agents.

4
New cards

What role does pharmacogenomics play in relation to butyrylcholinesterase?

It affects the duration of neuromuscular blocking effects.

5
New cards

What are nicotinic ligands used for outside of medicine?

They are used as pesticides and insecticides.

6
New cards

What type of receptor are Nicotinic Acetylcholinergic (nAChR) channels?

Ligand-gated ion channels.

7
New cards

What is the subunit composition example of nAChR mentioned?

(α4)3(β2)2.

8
New cards

Where are nAChRs found in the body?

In ganglia, neuromuscular junctions, and parts of the brain.

9
New cards

What neurotransmitter is present at both SNS and PSNS ganglia?

Acetylcholine.

10
New cards

Which blocking agents possess the necessary affinity to nicotinic receptors but lack intrinsic activity?

Non-depolarizing competitive ganglionic blocking agents.

11
New cards

What is the function of Trimethaphan (Arfonad®)?

It is used as a ganglionic blocker in hypertension and anesthesia.

12
New cards

Why were ganglionic blocking agents discontinued for hypertension treatment?

Due to numerous undesirable side effects.

13
New cards

What drug class is Mecamylamine (Inversine®; Vecamyl®) associated with?

Non-depolarizing noncompetitive ganglionic blocking agents.

14
New cards

What is the effect of ganglionic blockade on arterioles?

Causes vasodilation and increased peripheral blood flow.

15
New cards

What is the effect of ganglionic blockade on the heart?

It may lead to tachycardia.

16
New cards

What is curariform or curarimimetic activity associated with?

Neuromuscular blocking agents' ability to cause muscle relaxation in surgery.

17
New cards

What are the characteristics of nondepolarizing blocking agents?

They are competitive antagonists that prevent depolarization of muscle end-plates.

18
New cards

What happens to muscles when mixed with depolarizing blocking agents?

They become insensitive due to desensitization.

19
New cards

What distinguishes competitive (nondepolarizing) blockers from depolarizing ones?

Competitive blockers are bulky and rigid; depolarizing blockers are smaller and more flexible.

20
New cards

What historical discovery is linked to the development of neuromuscular blocking agents?

The use of curare by South American natives.

21
New cards

What critical milestone occurred in 1956 in relation to ganglionic blockers?

Mecamylamine was the first orally available antihypertensive agent.

22
New cards

When was pure tubocurarine first isolated?

In 1943 by Wintersteiner and Dutcher.

23
New cards

Which neuromuscular agent is indicated for skeletal muscle relaxation during anesthesia?

Atracurium besylate (Tacrium®).

24
New cards

What is unique about Cisatracurium compared to Atracurium?

It is 3-5 times more potent and has a shorter half-life.

25
New cards

What type of mechanism does Cisatracurium metabolism involve?

Ester hydrolysis and Hoffman elimination.

26
New cards

What is Mivacurium chloride known for?

A neuromuscular blocker with a shorter duration of action due to rapid ester hydrolysis.

27
New cards

What kind of neuromuscular blocking agent is Succinylcholine chloride?

A depolarizing neuromuscular blocker used during intubation.

28
New cards

What is a common consequence of prolonged effects from succinylcholine?

It occurs in patients with BChE mutations.

29
New cards

What innovative drug acts to reverse neuromuscular blockade induced by rocuronium?

Sugammadex (Bridion®).

30
New cards

What is the major characteristic of Imidacloprid as a pest control agent?

It binds more effectively to insect nAChRs than to mammalian receptors.

31
New cards

What are conopeptides?

Small peptides from cone snails that can paralyze their prey.

32
New cards

How does Ziconotide function in pain management?

As an N-type calcium channel antagonist.

33
New cards

What class of insecticides are derived from the exploration of nicotinic receptors?

Neonicotinoids.

34
New cards

What impact did the discovery of Imidacloprid have on pesticide development?

It led to extensive research on neonicotinoids.

35
New cards

What phenomenon occurs when muscle end-plate response diminishes with depolarizing agents?

Desensitization or tachyphylaxis.

36
New cards

What structural characteristics do competitive neuromuscular blockers have?

Large, bulky, and relatively rigid molecules.

37
New cards

In terms of structure, how do depolarizing agents differ from non-depolarizing agents?

They are smaller and more flexible.

38
New cards

Why is it critical to understand the pharmacogenomics of butyrylcholinesterase?

It helps predict patient response to succinylcholine.

39
New cards

How does the structure of pancuronium influence its function?

It possesses two bulky, positively charged centers separated by a steroid framework.

40
New cards

What adverse effect can occasionally occur with Rocuronium?

Allergic reactions in some patients.

41
New cards

What is the common indication for Vecuronium?

Adjunct in general anesthesia.

42
New cards

What is the significance of hexamethonium and decamethonium?

They illustrate the structure-activity relationship in neuromuscular blockers.

43
New cards

What biological effects does curare produce when used as an arrow poison?

Paralysis of skeletal muscles.

44
New cards

What is the primary function of neuromuscular blockers in surgical settings?

Facilitate muscle relaxation.

45
New cards

What is the potential benefit of sugammadex over succinylcholine?

It can allow greater flexibility in surgical timing and patient safety.

46
New cards

Why were certain neuromuscular blocking agents discontinued?

Due to safety and efficacy issues.

47
New cards

What role does acetylcholine play in the autonomic nervous system?

It acts as a neurotransmitter at ganglia in both SNS and PSNS.

48
New cards

Which condition is treated by nondepolarizing ganglionic blocking agents?

Hypertension.

49
New cards

What is the therapeutic use of Atracurium?

Adjunctive use in anesthesia for muscle relaxation.

50
New cards

How does the structure of neuromuscular blockers affect their action?

Molecule size and rigidity influence their receptor affinity and action.

51
New cards

What kind of muscle response is typically induced by succinylcholine during medical procedures?

Rapid muscle relaxation.

52
New cards

What is a critical consideration when using agents at neuromuscular junctions?

Balancing efficacy with potential side-effects.

53
New cards

What concept does the term 'pachycurares' refer to?

Historically used term for large, rigid neuromuscular blockers.

54
New cards

What is the significance of drug interactions with neuromuscular blockers?

They can alter drug effectiveness and patient outcomes.

55
New cards

Name a neuromuscular blocking agent with a very rapid onset.

Succinylcholine.

56
New cards

What is a characterized use of conotoxins in laboratory settings?

Research into neuromuscular pathways.

57
New cards

Mention a side effect often associated with ganglionic blocking agents.

Hypotension.

58
New cards

How can the action of nondepolarizing blockers be reversed?

By administering acetylcholinesterase inhibitors.

59
New cards

What factors can alter the effects of neuromuscular blockers in patients?

Genetic variations in butyrylcholinesterase.

60
New cards

What aspect of pharmacology is critical in drug development for neuromuscular agents?

Understanding the structure-activity relationship.

61
New cards

Which agent is now primarily used in the clinical setting as a ganglionic blocker?

Mecamylamine.

62
New cards

What critical aspect should be assessed before administering succinylcholine?

The patient's butyrylcholinesterase phenotype.

63
New cards

Why might tubocurarine be deemed unsafe for contemporary use?

It has excessive side effects compared to newer alternatives.

64
New cards

What does re-challenge with depolarizing blockers lead to?

Insensitivity of the muscle to further stimulation.

65
New cards

How long can succinylcholine effects last?

Typically between four to six minutes.

66
New cards

What receptor activity is directly affected by Imidacloprid?

Nicotinic acetylcholine receptors.

67
New cards

Describe the relationship between hexamethonium and tubocurarine.

Hexamethonium is a shorter-acting analogue of tubocurarine.

68
New cards

What innovative research method has been linked to understanding insecticide action?

Study of nicotinic receptors in insects.

69
New cards

Identify a significant drawback of traditional ganglionic blocking agents.

They have many undesirable side effects.

70
New cards

What physiological impact do neuromuscular blockers have during surgical procedures?

They induce relaxation of skeletal muscles.

71
New cards

What necessitated the development of sugammadex?

To provide a rapid way to reverse the effects of neuromuscular blockers.

72
New cards

What condition does Mivacurium treat?

It is a neuromuscular blocker used for muscle relaxation.

73
New cards

What is necessary to reverse the action of neuromuscular blockers?

The administration of acetylcholinesterase inhibitors.

74
New cards

What distinguishes succinylcholine from other neuromuscular blockers?

Its rapid onset and short duration of action.

75
New cards

Why was metocurine discontinued?

Due to its safety profile compared to other agents.

76
New cards

What is the mechanism of action for nondepolarizing neuromuscular blocking agents?

They compete with ACh for binding to nAChR.

77
New cards

What historical context should pharmacologists consider regarding neuromuscular blocking agents?

Their origins stem from hunting poisons like curare.

78
New cards

What is the primary predictor of response to succinylcholine?

Butyrylcholinesterase activity.

79
New cards

What is the structural requirement for competitive neuromuscular blockers?

They need to be bulky to prevent ACh binding.

80
New cards

Which neurotransmitter is responsible for parasympathetic responses?

Acetylcholine.

81
New cards

How do nondepolarizing blockers affect nerve impulses?

By reducing effective receptor activation, they prevent action potentials.

82
New cards

What are the typical side effects associated with neuromuscular blockers?

They may include cardiovascular effects and prolonged paralysis.

83
New cards

What therapeutic advantage does cisatracurium offer?

Less histamine release compared to atracurium.

84
New cards

What is the relevance of studying nicotinic antagonists derived from venoms?

To develop novel therapeutics against pain and neuromuscular disorders.

85
New cards

What muscle-related condition can succinylcholine be critical in managing?

Muscle paralysis for rapid intubation.

86
New cards

What links both succinylcholine and conotoxins?

Their ability to induce paralysis via nicotinic receptors.

87
New cards

Why do neuromuscular blockers represent a vital component of anesthesia?

To promote muscle relaxation and immobility during surgery.

88
New cards

What characteristic is essential for drug efficacy in neuromuscular blockers?

Binding affinity to nicotinic acetylcholine receptors.

89
New cards

How does suxamethonium act differently than traditional neuromuscular blockers?

It causes depolarization followed by desensitization.

90
New cards

Name an effective reversal agent for neuromuscular blockade.

Sugammadex.

91
New cards

What legislative changes are impacting the practice of administering neuromuscular blockers?

Regulations on anesthetic practices and neuromuscular monitoring.

92
New cards

Which producer was pivotal in the formulation of synthetic neuromuscular blockers?

Pharmaceutical companies focusing on anesthetics.

93
New cards

What enzyme is crucial in modulating the action of succinylcholine?

Butyrylcholinesterase.

94
New cards

What structural aspect is common in neuromuscular blockers?

Positively charged centers to bind to the receptor.

95
New cards

Describe the activity of muscarinic receptors as it relates to cholinergic drugs.

They mediate effects in target organs of the autonomic nervous system.

96
New cards

What are the challenges with using neuromuscular blocking agents in pediatrics?

The variations in enzyme activity compared to adults.

97
New cards

How does acetylcholine influence muscle contractions?

By binding to nAChRs and inducing muscle action potentials.

98
New cards

Identify the primary concern with long-acting neuromuscular blockers.

Risk of prolonged paralysis and recovery issues.

99
New cards

What therapeutic areas might benefit from advances in neuromuscular drug design?

Surgery, pain management, and emergency medicine.

100
New cards

What common structure is found in many neuromuscular blocking agents?

A quaternary ammonium salt structure.